Results 41 to 50 of about 1,565 (240)

EXEMPLARITY OF DIFFÉRANCE

open access: yes, 2020
Since his early investigations on Husserl’s phenomenology, Derrida’s reading of the texts refersas différance to the difference of writing to speech and logos.
Memişoğlu, Enis
core  

Literature as a mode of thought: Derrida’s institution of différance [PDF]

open access: yesFilozofija i Društvo
In this article, I argue that literature represents a privileged modality for thinking institutionality in Derrida’s work and, moreover, that literature represents a model for institutions.
Ó Fathaigh Cillian
doaj   +1 more source

Deep Sequencing of FLT3‐ITD Enables Response Evaluation and Post‐Treatment Monitoring in Childhood AML: An Exploratory Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm   +11 more
wiley   +1 more source

Différance Animal/ Humano: deconstrucción epistemológica

open access: yesPangeas, 2019
Esta investigación recupera los análisis deconstructivos sobre el límite teórico entre los conceptos de “animalidad” y “humanidad” que Jacques Derrida realiza en numerosos lugares de su obra, aunque muy especialmente en el recopilatorio de conferencias ...
Esther Zarzo
doaj   +1 more source

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke   +4 more
wiley   +1 more source

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook   +6 more
wiley   +1 more source

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási   +14 more
wiley   +1 more source

Life and the Technical Transformation of Différance: Stiegler and the Noopolitics of Becoming Non-Inhuman [PDF]

open access: yes, 2016
Through a re-articulation of Derridean différance, Bernard Stiegler claims that the human is defined by an originary default that displaces all psychic and social life onto technical supplements. His philosophy of technics re-articulates the logic of the
Turner, Ben, Turner, B
core   +1 more source

DİFFÉRANCE’IN SERÜVENİ

open access: yesFelsefe Dünyası, 2012
Bu çalışmanın temel amacı différance’ın kavram olmadığını, mevcudiyetmetafiziğine karşı indirgenemezliğini vurgulamaktır. Bu yüzden ne olduğununanlaşılması için ayrıntılı olarak ele alınmıştır.
Adem Yıldırım
doaj  

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy